Literature DB >> 30679851

Medication-related osteonecrosis: Patients with a hidden risk of MRONJ.

H Antov.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30679851     DOI： 10.1038/sj.bdj.2019.58

Source DB:  PubMed          Journal:  Br Dent J        ISSN： 0007-0610            Impact factor:   1.626


× No keyword cloud information.
  5 in total

Review 1.  Treatment of osteoporosis in women intolerant of oral bisphosphonates.

Authors:  Terry J Aspray; Roger M Francis
Journal:  Maturitas       Date:  2011-11-10       Impact factor: 4.342

Review 2.  Adverse effects of bisphosphonates: implications for osteoporosis management.

Authors:  Kurt A Kennel; Matthew T Drake
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

3.  Oral health management of patients at risk of medication-related osteonecrosis of the jaw.

Authors: 
Journal:  Br Dent J       Date:  2017-06-23       Impact factor: 1.626

Review 4.  Diagnosis of osteoporosis and assessment of fracture risk.

Authors:  John A Kanis
Journal:  Lancet       Date:  2002-06-01       Impact factor: 79.321

Review 5.  Bisphosphonates: mechanism of action and role in clinical practice.

Authors:  Matthew T Drake; Bart L Clarke; Suneep Khosla
Journal:  Mayo Clin Proc       Date:  2008-09       Impact factor: 7.616
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.